Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -142,623 | -136,214 | -95,248 | -38,602 | -157,846 |
| Depreciation Amortization | 1,876 | 1,763 | 1,641 | 801 | 3,276 |
| Accounts receivable | -8,789 | -2,602 | -5,868 | -11,445 | 4,771 |
| Accounts payable and accrued liabilities | -9,038 | -9,970 | -8,680 | -2,461 | 2,462 |
| Other Working Capital | -25,355 | -17,230 | -14,168 | -29,515 | 3,826 |
| Other Operating Activity | 42,755 | 54,202 | 41,902 | 24,888 | 19,676 |
| Operating Cash Flow | $-141,174 | $-110,051 | $-80,421 | $-56,334 | $-123,835 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 395 | -264 | -264 | -264 | -867 |
| Investing Cash Flow | $395 | $-264 | $-264 | $-264 | $-867 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 152,459 | 94,106 | 94,304 | 271 | 98,217 |
| Other Financing Activity | -1,514 | -250 | -250 | 0 | -1,163 |
| Financing Cash Flow | $150,945 | $93,856 | $94,054 | $271 | $97,054 |
| Exchange Rate Effect | 305 | 330 | 324 | 161 | -83 |
| Beginning Cash Position | 250,867 | 250,867 | 250,867 | 250,867 | 278,598 |
| End Cash Position | 261,338 | 234,738 | 264,560 | 194,701 | 250,867 |
| Net Cash Flow | $10,471 | $-16,129 | $13,693 | $-56,166 | $-27,731 |
| Free Cash Flow | |||||
| Operating Cash Flow | -141,174 | -110,051 | -80,421 | -56,334 | -123,835 |
| Capital Expenditure | -264 | -264 | -264 | -264 | -867 |
| Free Cash Flow | -141,438 | -110,315 | -80,685 | -56,598 | -124,702 |